Dr. Qi is the Founder & Chair of Chinese Portal Hypertension Alliance (CHESS), a group involves over 500 hospitals across China and has very close collaborations with hepatologists and gastroenterologists in US, Europe, and Asia. He is also the Chair of Committee of Portal Hypertension, China Association for Promotion of Health Science and Technology. His research interest and clinical practice focus on patient-oriented clinical and translational research about the whole-course management of portal hypertension and cirrhosis. He has published more than 130 peer-reviewed articles with a total citation number around 4,000 times.

Digestive Disease Research Center, Medical University of South Carolina, US

Dr. Don C. Rockey has active research portfolio’s in basic as well as clinical science. The general focus of his basic science research has been the study of wound healing, using the liver as a model system.  His laboratory was among the first to elucidate the importance of the hepatic stellate cell a hepatic myofibroblast.  His laboratory’s current work is focused on molecular mechanisms of the stellate cell to myofibroblast transition. Dr. Rockey has also been actively involved in clinical research focused on liver fibrosis and complications of cirrhosis; the overall direction of these studies has been to help establish management strategies for patients with chronic liver disease.  Dr. Rockey has authored and co-authored some 400 peer-reviewed manuscripts. He is a committed educator, and is a particularly dedicated mentor, having mentored nearly 150 different trainees, ranging in experience from medical students to junior faculty members.  

Dr. Bettinger is a consultant in internal medicine and hepatology and gastroenterology at the University Medical Center Freiburg in Germany. His research focuses on tailoring care to individuals with liver cirrhosis and portal hypertension as well as patients with hepatocellular carcinoma. A special clinical and research focus is interventional hepatology with implantation of transjugular intrahepatic portosystemic shunt (TIPS). His group works on research projects analyzing technical and prognostic factors in patients with TIPS implantation. Moreover, he has a strong interest in optimization of diagnosis and interventional treatment of non-cirrhotic portal hypertension, especially in non-cirrhotic portal vein thrombosis and treatment improvement in patients with Budd-Chiari syndrome.

Dr. Colecchia is a Full Professor of Gastroenterology & Hepatology at the University of Modena & Reggio Emilia. Dr. Colecchia obtained his medical degree at the University of Bologna, Italy. In 2017 he became the head of the Gastroenterology Unit in Verona, Italy, before assuming his current position in 2021. His research interests focus on the diagnosis and treatment of advanced chronic liver disease, portal hypertension complications and hepatocellular carcinoma, with a special interest in imaging techniques and non-invasive tools, including ultrasound and elastography. He first investigated the role of spleen stiffness measurement in portal hypertension assessment and vascular liver diseases. He is a member of the European Association for the Study of the Liver (EASL), Italian Association for the Study of the Liver (AISF) and the Vascular Liver Disease Group (VALDIG). He has published more than 167 articles in international peer-reviewed journals with an H-Index of 41 and more than 6,400 citations.

Dr. Enomoto is an associate professor of the Hyogo College of Medicine. He has been working in the field of the basic and clinical gastroenterology. In the graduate school of medicine, he studied the mechanisms of cell growth and differentiation using various techniques of the molecular biology. Current his major working field is the basic and clinical hepatology. He has published more than 130 papers in relation to the diagnosis and treatment for chronic liver diseases, including various complications of liver cirrhosis such as portal hypertension and hepatocellular carcinoma.

1998-2006: Staff Physician, Dept of Gastroenterology & Nephrology, Chiba University Hospital; 2006-2009: Assistant Professor, Dept of Gastroenterology & Nephrology, Chiba University Hospital; 2009-2011: Division of Gastroenterology and Hepatology, Virginia Commonwealth University, USA; 2011-2013: Assistant Professor, Dept of Gastroenterology & Nephrology, Chiba University Hospital; 2013: Associate Professor, Dept of Gastroenterology & Nephrology, Chiba University Graduate School of Medicine; 2019-present: Associate Professor, Dept of Gastroenterology, Juntendo University.

Dr. Mindie H. Nguyen is Professor of Medicine, and by courtesy, of Epidemiology and Population Health, Director for the Hepatology Fellowship and Clerkship, a Member of the Appointment and Promotion Committee, and a Diversity Advisor for the Department of Medicine at Stanford University Medical Center. She is an active clinician and researcher in viral hepatitis, NAFLD, and liver cancer with over 250 original research publications including first/senior authorship in New Eng J Med, Lancet Gastroenterol Hepatol, Gastroenterology, J Hepatol, Hepatology, and JAMA NO. She has served as editorial/advisory board members for major journals. She has served as Chair of the Hepatitis B SIG and member of various standing committees for the AASLD. She has mentored over 150 trainees from high-school students to undergraduate, medical, Masters/PhD students clinical and research residents/fellows, and faculty at Assistant/Associate Professor rank.

Dr. Pavlides is the head of liver imaging at the Oxford Centre for Clinical Magnetic Resonance Research at the University of Oxford and an honorary consultant hepatologist at the John Radcliffe Hospital in Oxford, UK. His research focuses on the use of magnetic resonance technologies for the evaluation of patients with liver disease and spans the whole spectrum of investigation from small proof of concept studies to large multicenter clinical trials.  

Dr. Popov is currently directing a Liver Fibrosis Research Lab and Core and holding an appointment of Associate Professor of Medicine at Harvard Medical School. Prior to joining PH&C editorial team, he served as an Associate Editor of American journal of Physiology-Gastrointestinal and Liver Physiology, and is on editorial boards or ad hoc reviewer for over 30 scientific journals including Hepatology, Gastroenterology, Journal of Clinical Investigation and Science Translational Medicine. Dr. Yury Popov’s laboratory's major research focus is on liver fibrosis/cirrhosis and its life-threatening sequelae. His lab discovered several pathways responsible for fibrosis progression, including elucidation of the molecular mechanisms of fibrotic matrix stabilization and collagen cross-linking which make liver scarring irreversible, defining the role of TGFbeta-activating integrins in fibrosis progression and identification of mitochondrial DAMPs as a potent fibrogenic signal, with far reaching diagnostic and therapeutic implications.

Dr. Vilgrain’s major research interests are diagnostic and interventional imaging of the liver, pancreas and bile ducts. She is member of ESGAR Executive committee and she is the Scientific Director of ESOR (European School of Radiology). Since 2012 she has participated to many European guidelines on liver and pancreatic diseases. Dr. Vilgrain has published more than 500 peer-reviewed papers (H-Number: 78) and has been a principal investigator of several large multicenter clinical trials, including the SARAH trial. She has served on the Editorial Board of Radiology and she is currently on the Editorial Board of Abdominal Radiology. She is a reviewer for several high-ranked journals: Radiology, European Radiology, Gut, Hepatology, Journal of Hepatology, Liver Transplantation, and European Journal of Cancer.

Dr. Bae’s major scientific interests are diagnostic imaging of the liver, ranging from diffuse liver disease including liver cirrhosis or fatty liver to focal liver lesion such as hepatocellular carcinoma. As a radiologist, he has research experiences in imaging modalities including ultrasound, computed tomography, and magnetic resonance imaging. He is also interested in the risk stratification of oncologic patients undergoing radiological surveillance to provide individualized examination protocol in the era of personalized medicine. 

March 2012 – February 2013, Rotating Internship, Seoul National University Hospital, Seoul
March 2013 – February 2017, Radiology Residency, Seoul National University Hospital, Seoul
March 2017 – February 2018, Radiology Fellowship, Seoul National University Hospital, Seoul
March 2018 – Now, Assistant Professor, Seoul National University Hospital, Seoul

Dr. Cárdenas is a Staff Member and Consultant of the Institute of Digestive Diseases and Metabolism at Hospital Clinic and Associate Professor of Medicine at the University of Barcelona. Dr. Cardenas is Board Certified in Internal Medicine, Gastroenterology and Hepatology by the American Board of Internal Medicine. His main expertise and research interests are cirrhosis and its complications, interventional procedures in patients with cirrhosis and portal hypertension and biliary complications in liver transplant recipients. He has over 180 publications in peer-reviewed journals and over 80 chapters in medical textbooks and has authored a textbook on Complications of Cirrhosis.

Dr. Gracia-Sancho is a biochemist with more than 20-year experience of research in the field of basic and translational portal hypertension and vascular pathobiology of the liver. He (co-) authored more than 110 peer-reviewed manuscripts with 4900 citations. In addition, he is invited professor in different universities within Spain, Europe and China and co-leads diverse educational initiatives including the LiverSeminars Program, the 2018 EASL-Basic School of Hepatology, the 2020 APASL-Symposium on Regression of Portal Hypertension, and the 2021 EASL-Symposium on Sinusoidal Cells in Liver Diseases. Dr Gracia-Sancho has been invited speaker in different national and international conferences, including the annual meetings of the European, American and Asia-Pacific associations of Hepatology. He is member of the Basic Research Committee and the Portal Hypertension Special Interest Group Steering Committee of the AASLD. In 2016 he received the Emerging Leader Award from EASL.

Graduated at University of Zagreb School of Medicine in 1997. Consultant in internal medicine (2004) and gastroenterology (2008), PhD in medicine (2010). Postgraduate education: Medical School Hannover, Germany; University of Bologna, Italy; Royal Free Hospital, London, UK. Assistant Professor at University of Zagreb School of medicine (2012-); Associated Professor of medicine, University of Zagreb (2018-). Head, Department of hepatology (2011-), University hospital Dubrava, Zagreb. President, Croatian society of gastroenterology; Vice-president, Croatian Society of Ultrasound in Medicine and Biology. Governing board member, Central European hepatologic collaboration (CEHC). Founder of Adriatic Liver Forum. Fellow of the European board of gastroenterology and hepatology (FEBGH), Fellow of the Royal College of Physicians of London (FRCP). Scientific interest in Hepatology and Ultrasound. Publications: 75 papers, over 100 congress abstracts, 16 chapters in University manuals. Editorial board member and reviewer for several scientific journals.

Professor of Medicine, Department of Internal Medicine, Section of Digestive Diseases, Yale University, School of Medicine, New Haven, Connecticut, USA

Dr. Iwakiri is a Professor of Medicine at Yale University, U.S.A. Her lab conducts basic and translational research in liver fibrosis, portal hypertension and liver vascular biology. She has served as an Associate Editor for Hepatology twice and as an editorial board member for Journal of Hepatology, Hepatology International, Liver International, Liver Research and JHEP Reports. She has been serving as members for numerous grant review committees, including National Institute of Alcohol Abuse and Alcoholism (NIH/NIAAA), National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK), Department of Defense, Research Grants Council of Hong Kong, the Netherlands Organization for Scientific Research and Japanese governmental grant (AMED). She has published nearly 80 peer-reviewed articles with more than 6,000 times cited.

Associate Professor of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Dr. Jeong is an associate professor at Samsung Medical Center, Sungkyunkwan University School of Medicine. He has been working in the field of radiology. He has been interested in the role of radiology in liver cirrhosis, portal hypertension, and various hepatic diseases and published more than 140 researches about the new technology of ultrasound, CT, and MRI. His recent activities about scientific society are as follows. 1) Chair of the accreditation committee, Korean Society of Radiology, 2) Deputy Editor of Ultrasonography (the official journal of Korean Society of Ultrasound in Medicine), and 3) Chair of the scientific committee, Korean Society of Ultrasound in Medicine.

Professor in Diagnostic Imaging; Chair, Department of Radiology, Zhongda Hospital Southeast University, Nanjing, China

Dr. Ju is a professor in diagnostic imaging and the chair of the Department of Radiology at Zhongda Hospital, Southeast University in Nanjing, China. She serves as an executive member of ASAR (Asian Society of Abdominal Radiology) and a member of the standing committee of CSR (Chinese Society of Radiology).  Dr. Ju has been focusing on clinical practices in diagnostic imaging and basic research on Molecular Imaging. She has been in charge of over 10 programs, including Key Programs, Distinguished Young Scholar Programs of National Natural Science Foundation of China, etc. She has published more than 100 peer-reviewed articles with a total citation number over 2800 times.

Lecturer, Department of Gastroenterology, Nara Medical University, Nara, Japan 

Kosuke Kaji graduated from Nara Medical University, obtaining a medical license in 2003. He received his Ph.D. in Gastroenterology and hepatology from the Nara Medical University in 2010. His doctoral dissertation described the role of insulin resistance on liver fibrosis development and hepatocarcinogenesis. Dr. Kaji joined the laboratory of Dr. Snorri S Thorgeirsson (Laboratory of Experimental Carcinogenesis) at the National Cancer Institute (NCI), NIH in Bethesda USA in 2012 as a Research Fellow where his research has involved several genomic and epigenomic aspects of liver regeneration. In 2015, Kaji focused his research on the role of gut-liver axis on liver fibrosis development and the complications of liver cirrhosis including hepatic encephalopathy, skeletal muscle atrophy and portal hypertension. In 2018, Kaji was appointed Lecturer at Department of Gastroenterology in Nara Medical University.

Department of Radiology, Seoul National University Hospital, Seoul, South Korea

Prof. Lee is currently Professor, in radiology department at Seoul National University Hospital. He has published more than 470 scientific articles in international journals and is on the Editorial Board of several journals including Radiology, KJR, Cancer Imaging, and Liver Cancer. He also received Honorary fellow of ESGAR, and ISMRM fellow of society 2020, and is a formal member of The Korean Academy of Science and Technology, and National Academy of Medicine of Korea. In addition, he is the current president of the Korean Society of Radiology and had served as chair of the educational committee for Korean Society of Magnetic Resonance in Medicine. His main scientific interests include “MR Imaging diagnosis of Hepato-biliary and pancreatic diseases”, “Multiparameteric MRI for oncologic diseases”, “MR Elastography” and “Image guided tumor ablation”.

Prof. Lesmana is a senior Consultant in the Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia in Jakarta. He is also work at Digestive Disease & GI Oncology Centre (DDOC), Medistra Hospital, Jakarta as well as at Gastrointestinal Cancer Center, MRCCC Siloam Hospital, Jakarta. He carried out his medical and postgraduate training in Internal Medicine and in Gastroenterology/Hepatology at Diponegoro University, Semarang and Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta. He underwent several additional trainings abroad in advance endoscopy (ERCP), Fibroscan, and basic molecular hepatitis virus B. He further continued his portal hypertension training at Institute of Liver & Biliary Sciences (ILBS), New Delhi, India, and he underwent endoscopic ultrasound (EUS) training. He also has published many papers in peer-reviewed international journals.

Tenured Professor, Director, Institute of TCM-X, Tsinghua University, Beijing, China

Shao Li is a tenured professor at Tsinghua University, and the director of institute for TCM-X, Beijing. He proposed the “network target” concept and methodology to shift the “one target, one drug” approach, and is exploring a new way to the network-based precision Chinese Medicine on inflammation and cancer. He led the first international standard of network pharmacology, and published about 200 papers, which have been cited >7000 times. He held over 30 US and China patents. He was honored the 1st Prize of International Award for Contribution to Chinese Medicine, Li Shizhen Pharmaceutical Innovation Award, Leading talents of National Ten-Thousand Talents Program, National Science Fund for Distinguished Young Scholars, National Science & Technology Award, National Education Award, and National Excellent Doctoral Dissertation. He was selected in 2020 World's Top 2% Scientists, and Highly Cited Chinese Researchers (Elsevier).

University of Pittsburgh Medical Center, Pittsburgh, USA 

Dr. Liu’s research focuses on understanding the clinical and translational aspects of pancreatic cancer metastatic progression and tumor microenvironment. I am also working to understand and risk-stratify patients waiting for liver transplantation due to hepatocellular carcinoma. My long-term research interests involve investigating the complex biological behavior of primary and metastatic liver, bile duct, and pancreatic malignancies and developing novel treatment strategies for them, including therapies that combine transplant and surgical oncology.

Assistant Professor of Medicine, Department of Medical and Surgical Sciences, University of Bologna, Treasurer of the Italian Association of Young Gastroenterologists’ and Endoscopists’, Bologna, Italy 

Dr. Giovanni Marasco is a consultant in Internal Medicine and Gastroenterology at IRCCS S. Orsola Hospital of Bologna. His research activity is focused on the study of portal hypertension and other liver cirrhosis-related complications such as hepatocellular carcinoma and post-operative complications. During the last decades the Bologna research group produced several studies evaluating the usefulness of non-invasive tools for the assessment and staging of liver cirrhosis, portal hypertension and the prognosis of hepatocellular carcinoma patients. A collateral research field is the evaluation of gut microbiota composition and modulation with probiotics, antibiotics, and fecal microbiota transplantation in gastrointestinal and liver diseases.

Dr. Necati Örmeci graduated from the Ankara University Medical Faculty, where in 1980 he became a specialist in Internal Medicine, and in 1985 in Gastroenterology,in 1994 a professor of Gastroenterology.

As a Monbusho Scholarship recipient, he studied the early diagnosis of cancer in the gastrointestinal system for one and a half years in Japan. As a visiting professor, He worked with the Cleveland Clinic of Florida, in July of 1999. Presently, He is working in Istanbul Health and Technology University as a Vice-President and Dean of Medical Faculty. Currently, He has around 170 papers and chapters of 17 books. He is a permanent member of Turkish Sciences Academy.

Dr. Palaniyappan is a clinical associate professor in hepatology. His research focuses on advanced chronic liver disease and its complications. He has a special interest in  diagnostic and prognostic utility of non-invasive imaging markers (e.g. multiparametric MR imaging) in evaluating portal pressure in cirrhosis.

Dr. Ravaioli is a consultant in Hepatology and Gastroenterology at Gastroenterology Unit, University Hospital of Modena, Modena, Italy. He graduated with M.D. from the School of Medicine of the University of Bologna, where his research focuses on portal hypertension and other complications related to advanced chronic liver diseases, hepatocellular carcinoma, esophageal varices, and liver transplantation. In particular, the group's focus is the application of non-invasive tools (liver elastography mainly) for prediction of natural history and staging of liver diseases and complications. Furthermore, his collaboration with other specialities has led to research on metabolic liver disease (MAFLD / NAFLD) in obesity and diabetes, vascular liver disease (such as VOD / SOS) in haematological settings, and clinical nutrition for liver disease.

Prof. Seto is currently a Clinical Professor in the Department of Medicine; and Principal Investigator of the State Key Laboratory of Liver Research, the University of Hong Kong. He is a Consultant in Gastroenterology and Hepatology in the University of Hong Kong Health System and a Chief Physician in Gastroenterology and Hepatology in the University of Hong Kong-Shenzhen Hospital. He has published more than 210 international journal articles and book chapters, including articles in the Lancet, J Clin Oncol, Lancet Global Health, J Hepatol, Gut, and Hepatology, majority related to research on chronic liver diseases. He has been awarded the American Gastroenterological Association Fellowship (2021); the Asia-Pacific Digestive Week Emerging Leader from the APDW Federation (2018); Guangdong Province Outstanding Young Medical Talent Award (2017); and the Outstanding Young Research Award (2016-2017) from The University of Hong Kong. 

Dr. Takehara is a physician scientist in hepatology and gastroenterology and his major research interests include, basic research on cell death and innate immunity and, clinically, viral and non-viral hepatitis, liver cirrhosis and hepatocellular carcinoma (HCC). He directs and oversees the Osaka Liver Forum (OLF) study, a large and comprehensive cohort study of hepatitis and HCC patients in the Kansai area. Currently, Dr. Takehara is the Director General of the Japan Society of Hepatology (JSH) and the Director of the Japanese Society of Gastroenterology (JSGE).

Dr. Tanwandee is hepatologist at Division of Gastroenterology at Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand where he has been working for more than 30 years. He is immediate past president of the APASL and was past president of Thai Association for the Study of the Liver (THASL), and president of the 4th ASEAN Perspective in Liver Diseases (APLD) 2016. His research interest is about treatment of chronic hepatitis B and C, cirrhosis, hepatocellular carcinoma and cost effective of treating hepatitis B and C. He has published more than 100 peer-reviewed articles with a total citation number over 4400 times.

Dr. Treeprasertsuk ‘s medical education was as follows: M.D. from Mahidol University, Ramathibodi Hospital, Faculty of Medicine, Thailand (1991). M.Sc. in Clinical Translational Science, CTS, from Mayo Clinic, Mayo Graduate School. Research Fellow in Clinical Liver Research, Division of Gastroenterology and Hepatology, Mayo Clinic (2010). Ph.D. in Medicine from Chulalongkorn University (2012). Currently, he is an Assistant to President, for Cross functions, Chulalongkorn University, Bangkok, Thailand (2018-present). His area of research interests include NASH, Cirrhosis, HCC, ACLF, and Transient elastography. He has published 1140 documents with an H-index of 30.

Professor, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Dr. You is a professor at the Liver Research Center, Beijing Friendship Hospital, Capital Medical University, in Beijing (China). She is one of the Executive Committee member of the Asian Pacific Association of the Study of Liver Diseases (APASL), and Vice President of Chinese Society of Hepatology, Chinese Medical Association. She has been the principal investigator in 3 recent studies involving hepatitis, NASH and cirrhosis, and has numerous articles and book chapters in medical journals addressing liver fibrosis and cirrhosis.

Chairman and Professor of the Department of Gastroenterology, Nara Medical University, Japan

Dr. Yoshiji is a councilor of many academic societies, such as The Japanese Society of Gastroenterology, The Japanese Society of Hepatology, The Japanese Society of Portal Hypertension, and The Japanese Society of Internal Medicine. He is the Editor-in-Chief of the Japanese Journal of Gastroenterology, the Japanese Journal of Portal Hypertension, Managing editor of Hepatology Research, and an Editorial Board of fifteen International Academic Journals. He is also the chair of the Japanese guideline committee of liver cirrhosis 2020. He has many high-index articles. According to Thomson Reuters, he used to rank among the top 1% of most-cited Japanese researchers cited in Pub Med Central. 

Vice President, Professor of Emergency Surgery, Union Hospital affiliated with Huazhong University of Science and Technology, Wuhan, China 

Dr. Zhang Specializes in emergency abdominal surgery and the treatment of multiple injuries, carrying out surgical treatment by rapid rehabilitation surgery and endoscopic minimally invasive surgery.During the fight against COVID-19, he served as the president of the makeshift hospital in Jianghan District of Wuhan, and as the leader of the medical team to support Beijing in increasing its nucleic acid testing capacity. Dr. Zhang currently serves as the chairman of commitee of the Wuhan Emergency Medicine Branch. He has been working in the front line of clinical emergency medicine for more than 20 years, and has been engaged in the mechanism research of inflammatory storm and liver reperfusion injury. He has published more than 30 SCI indexed papers as the corresponding author or first author in journals as JAMA, Hepatology, Frontiers in Immunology, Surgical Endoscopy, etc.

Dr. Zhang, a postdoctoral fellow at Vanderbilt University, USA, is currently the vice director of the Clinical Center for Liver Surgery. He also serves as the National Committee of Laparoscopic and Endoscopic Surgery of the Surgery Branch of the Chinese Medical Association; the Secretary of the Expert Committee for the Promotion and Development of Laparoscopic Hepatectomy of the Asia-Pacific Hepatobiliary and Pancreatic Association. Clinical work is proficient in the minimally invasive treatment of liver, bile duct, pancreas and spleen under laparoscopy. The main areas of research are clinical and translational research in complex liver tumours, cirrhotic portal hypertension, metastatic liver cancer, and cholangiocarcinoma. Research articles have been published in influential international journals such as Nature Communication, Ann Surg Oncol, Surgery, and Surg Endosc.

Dr. Zheng had founded the PERSONS platform and has dedicated to the development of its infrastructure since 2016-12-07. PERSONS is the acronym for Prospective Epidemic Research Specifically Of NASH. The database is an ongoing prospective cohort consisting of more than 1300 cases of biopsy-proven NAFLD (2021-07-01) and supported by a multidisciplinary team. The team boasts its advantage in patient data collection across multiple fields of medicine including nutrition, sports, hepatology, endocrinology, cardiology, psychology, pathology, and radiology. The team of doctors specialized in each of these fields contribute in a consistent manner to ensure continuity and steady growth of database. Moreover, biobank including blood, urine, stool, pathology slides (digitized by scan), and liver tissue samples, are collected and stored in the same day of biopsy. He has published more than 200 peer-reviewed articles with H index 36.

Dr. Wong is a consultant from Changi General Hospital, Singapore and an assistant professor from Duke-NUS Medical School, Singapore. His research interest and clinical practice focus on personalized management of portal hypertension, cirrhosis and hepatitis C. He has published more than 40 peer-reviewed articles with a total citation more than 800 times.

Weiyan Jiang has mature creative experience in medical illustration and data visualization. She is pursuing for master's degree on school of communicaiton, Soochow University, China. Her research is on science communication and visualization construction of academic journals. She was the editor of more than 100 medical monographs and published lots of in-depth medical interviews as an academic editor in a medical publishing company.

Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences , Peking University Health Science Center, Beijing, China

Dr. Liu obtained her MD from Southern Medical University in 2020, with major in Clinical Medicine. She is now a postdoctoral scholar in Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. The general focus of her research has been the non-invasive diagnosis and monitoring of portal hypertension. She has published more than 20 peer-reviewed articles with a total citation number around 200 times.

Ningning Wang, Chinese Medical Association Publishing House, Beijing, China

Ningning Wang is the managing editors of Portal Hypertension & Cirrhosis, editor of Chinese Medical Journal (Responsible on Cardiology, Cardiovascular surgery, Vascular surgery, Orthopedics, and Plastic & Burn). She received her bachelor degree on clinical medicine and MA.Sc (surgery) from West China Medical Center/Sichuan University. Ningning Wang has published many articles on medical journal management.

Wanshu Zhang, John Wiley & Sons, Inc.

Wanshu Zhang obtained her B.Sc. from the University of Science and Technology Beijing (USTB). She conducted her Ph.D. study at Peking University based on a cooperation project with USTB. After her post-doctoral research at Eindhoven University of Technology, she joined Wiley as a journal publishing manager. At present, she is overseeing a portfolio of scientific journals in health sciences. Her responsibility also includes managing partnership journal business with Chinese societies.

Siyue Xiao, John Wiley & Sons, Inc.

Siyue Xiao received her MSc from University of Warwick, Coventry, UK, with major in e-Business Management, and further acquired a Postgraduate Diploma in Asian Arts from SOAS, University of London, London, UK, in pursuing her interests in art history. She has worked in a literature agency handling foreign book rights for 2.5 years before she joined Wiley as a Journal Publishing Assistant in Health Sciences team.